This webinar will discuss the FDA requirements and guidelines for investigating Out-of-trend (OOT) results in the pharmaceutical laboratory. It will also cover FDA-compliant documentation of OOT, failure investigations, root causes, and CAPA.
FDA's guidance on OOS test results requires failure investigations and other steps for Out-of-Specification (OOS) and Out-of-trend (OOT) results. While most companies are familiar with and have procedures for OOS results, this is not the case for OOT situations. The guide states: "Although the subject of this document is OOS results, much of the guidance may be useful for examining results that are out of trend". Managing OOT results also helps to avoid time-consuming OOS results. The industry is unsure how to interpret and implement the FDA guidance.
This session will equip you with the knowledge and comprehensive understanding of FDA requirements for Out-of-Trend Results in pharmaceutical quality control.
FDA's guidance on OOS test results requires failure investigations and other steps for Out-of-Specification (OOS) and Out-of-trend (OOT) results. While most companies are familiar with and have procedures for OOS results, this is not the case for OOT situations. The guide states: "Although the subject of this document is OOS results, much of the guidance may be useful for examining results that are out of trend". Managing OOT results also helps to avoid time-consuming OOS results. The industry is unsure how to interpret and implement the FDA guidance.
This session will equip you with the knowledge and comprehensive understanding of FDA requirements for Out-of-Trend Results in pharmaceutical quality control.
Kelly Thomas
Ms. Thomas has over two decades of cGMP hands-on industry experience in both pharmaceutical and medical device manufacturing operations. Her experience covers all Quality Systems; as well as, all areas of validation; including, process/product validation, facilities validation, CSV and 21 CFR Part 11, test method validation, equipment/automated processes and cleaning validation.Utilizing strategic thinking, risk based approaches, and Lean principles, she has demonstrated success in steering and managing complex projects within the pharmaceutical and medical device industries.
Effective Communication: Ensuring Clarity, Accountability a…
2-Hour Virtual Seminar on Workplace Investigations 101: How…
Employers Should Prepare for Immigration Raids in 2026! Thi…
AI for Excel Professionals: Enhancing Productivity with Cha…
The Importance of the first 5 seconds when presenting
Negotiating Skills For Professional Results - Winning Strat…
Workplace Behavior in 2026: Tackling Conflicts and Incivili…
FDA Recommendations for Artificial Intelligence/Machine Lea…
Validation Statistics for Non-Statisticians
Bootcamp for New Managers and Supervisors: Develop These Es…
Interactive dashboards & analytics in Excel
Enhancing Project Management with Storytelling Techniques
4-Hour Workshop on Data Simplified: Sorting and Filtering, …
Creating Your 2026 Marketing Strategy
The Language of Leadership: Is Your Communication Style As …
ChatGPT for Innovative Business Advisory Services for Accou…
Utilizing A Proven Process When Conducting Sensitive, Inter…
How to Write Procedures to Avoid Human Errors
Human Factors Usability Studies Following ISO 62366 and FDA…
Why EBITDA Doesn't Spell Cash Flow and What Does?
Mastering DAX Patterns in the Era of AI & Copilot
Establishing Appropriate Quality Metrics and Key Performanc…
IRS Form 1099 Reporting: Compliance Requirements
FDA QMSR Explained: How the QMSR Replaces the QSR
How to Manage the Legal Landmine of the FMLA, ADA and Worke…
Understanding EBITDA – Definition, Formula & Calculation
Tattoos, hijabs, piercings, and pink hair: The challenges …
FDA Compliance And Laboratory Computer System Validation
Medical Device Hazard analysis following ISO 14971
Excel Spreadsheets; Develop and Validate for 21 CFR Part 11…
Excel + AI: The Smart User's Guide to Faster, Easier Work w…